11.98
price up icon0.84%   0.10
after-market 시간 외 거래: 11.94 -0.04 -0.33%
loading

Entrada Therapeutics Inc (TRDA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
19.52%
1.299
1.614 1.95 20.56 19.57
Operating Expenses
10.60%
43.51
48.66 48.80 42.35 41.23
Benefits Costs and Expenses
-
- - 37.91 -
Costs And Expenses
10.60%
43.51
48.66 48.80 37.91 41.23
Operating Income/Loss
10.29%
-42.21
-47.05 -46.85 -21.79 -21.66
Income/Loss From Continuing Operations Before Tax
19.52%
1.299
1.614 -43.10 -17.35 19.57
Income Tax Expense/Benefit
85.93%
0.092
0.654 0.178 - -1.86
Income/Loss From Continuing Operations After Tax
11.26%
-39.16
-44.13 -43.10 -17.35 -14.03
Net Income/Loss
11.26%
-39.16
-44.13 -43.10 -17.35 -14.03
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.81%
0.0784
41.46 41.34 41.07 40.63
Diluted Average Shares
99.81%
0.0784
41.46 41.34 41.07 40.63
Basic Earnings Per Share
11.32%
-0.94
-1.06 -1.04 -0.42 -0.35
Diluted Earnings Per Share
11.32%
-0.94
-1.06 -1.04 -0.42 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):